SlipstreamJobs tracks this role from the company's public career site. Apply directly on the employer's site.
Ataraxis AI is a clinical AI research lab at the intersection of multi-modal AI and precision medicine, with a mission to make disease predictable. The company develops AI methods that predict patient outcomes and treatment response, and builds clinical tools to assist physicians in selecting optimal treatments. Ataraxis has developed foundation models for digital pathology (Falcon and Kestrel), causality research (Ataraxis™ Tau), and survival analysis. The company's first clinical products, including Ataraxis™ Breast for breast cancer, are already deployed across academic institutions and community clinics worldwide. Ataraxis has raised over $24 million in funding, including a $20 million Series A led by Thiel Capital/Founders Fund, Obvious Ventures, and AIX Ventures. The company's advisors include AI pioneer Yann LeCun and distinguished oncologists from top cancer research institutions.
In this role, you will aggressively drive sales growth and market penetration of Ataraxis oncology products through direct sales to individual oncologists within your designated territory in Georgia and Alabama. You will be responsible for prospecting new business and maintaining relationships with existing clients. This is an opportunity to shape the future of precision medicine while working with a flat organizational structure where every team member is empowered to contribute actively.
REQUIREMENTS:
- Minimum 2 years of demonstrated high-performance sales experience in oncology, especially in breast cancer
- Proven track record of consistently exceeding sales quotas with demonstrated achievement through awards or recognition (e.g., President's Club, Rookie of the Year)
- Passionate about AI and innovation in healthcare, with ability to learn and effectively communicate AI-based diagnostic solutions
- Autonomous, capable of excelling independently in a hyper-growth start-up environment
- Ability to thrive in a highly competitive environment; demonstrates resilience, urgency, and focus on closing deals
